Clinical Trial Update: The Combined Effect of N-Acetyl Cysteine and Metformin in Polycystic Ovary Syndrome Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is investigating the combined effect of N-acetylcysteine and metformin for polycystic ovary syndrome and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)
• metformin (metformin)

Snippet

Sponsor: Cairo University | Conditions: Polycystic Ovary Syndrome | Phase 3 | Status: RECRUITING